Last fall's anthrax attacks, and the fear and confusion that followed, made it all too clear that the United States lacks a comprehensive strategy for coping with bioterrorism. For too long, thinking about biological weapons has been held hostage to misplaced analogies to nuclear or chemical weapons. An effective strategy must begin by focusing on the special challenges posed by biological threats.
Christopher F. Chyba is Co-director of Stanford University's Center for International Security and Cooperation and holds the Carl Sagan Chair for the Study of Life in the Universe at the SETI Institute. He served on the staff of the National Security Council in the Clinton administration.
MISPLACED ANALOGIES
The anthrax attacks on the United States in the autumn of 2001, and the fear and confusion that followed, made clear that the country lacks a comprehensive strategy for biological security -- the protection of people and agriculture against disease threats, whether from biological weapons or natural outbreaks. Too often, thinking about biological security has been distorted by misplaced analogies to nuclear or chemical weapons. An effective strategy must leave these analogies largely behind and address the special challenges posed by biological threats.
A strategy for biological security must confront drug-resistant and emerging diseases -- more than 30 of which have entered the human population over the past quarter-century. There is no good analogue to this naturally occurring threat in the realm of nuclear or chemical weapons. Moreover, diseases may be targeted against livestock or crops as well as against human populations. And outbreaks of deadly, contagious, and long-incubating diseases such as smallpox have to be detected and stopped rapidly wherever in the world they occur. Fortunately, once formulated, a sound strategy for biological security will help sustain itself because many of its core provisions will benefit public health even apart from acts of bioterror.
In fact, many of the tools used to address natural disease threats will be needed to respond to an intentional attack. The U.S. response to the anthrax attacks has emphasized the importance of improving domestic defenses. These measures include stockpiling vaccines and antibiotics, as well as improving local and national disease surveillance and other public health tools. To be effective these domestic measures must be sustained for decades and keep pace with the biotechnology revolution. International steps -- such as improving surveillance for and response to outbreaks of infectious diseases and securing pathogen stocks worldwide -- are also crucial to an effective strategy. Yet most of these international measures have been ignored so far in the current focus on immediate domestic needs.
This is a premium article
You must be a Foreign Affairs subscriber to continue reading. If you are already a print subscriber, click here to activate your online access.
Log In
Buy PDF
Buy a premium PDF reprint of this article.Related
Although terrorism is a top U.S. concern, the State Department's annual terrorism report was riddled with errors. If Washington wants to win the war, it needs to get its facts straight.
The United States may be an uncontested military superpower, but it remains defenseless against a new mode of attack: information warfare. As the military, the private sector, and Washington grow increasingly dependent on computers and information networks, they also grow more vulnerable to cyber-attack. Cyberspace is becoming the new front line of warfare, and private citizens are the new prime target. U.S. policymakers and technology entrepreneurs must wake up to this threat and build a wall of defense -- now.
Despite all the ominous warnings of wily terrorists and imminent attacks, there has been neither a successful strike nor a close call in the United States since 9/11. The reasonable -- but rarely heard -- explanation is that there are no terrorists within the United States, and few have the means or the inclination to strike from abroad.
